PDL BioPharma Inc. PDLI

Mike Chrisman

[queue]

close 10.61 Mike Chrisman Recommends the Following Stocks: NTAP, and PDLI 3 Jun 2002, 06:00am ET E-mail or Print this story [prnewswire] - - - - - /FROM PR NEWSWIRE CHICAGO 888-776-6551/ [STK] NTAP PDLI [IN] FIN PUB MAG [SU] INO -- WITH PHOTO -- TO BUSINESS EDITOR: Mike Chrisman Recommends the Following Stocks: NTAP, and PDLI CHICAGO, June 3 /PRNewswire/ -- While many blue chip companies are struggling through the first half of 2002, the small cap sector continues to produce profits for investors. Mike Chrisman, editor of the Hot Small Caps Newsletter, is already up over +31% YTD. Find out what small caps he likes and begin profiting today. https://www.featuredexpert2.zacks.com. (Photo: https://www.newscom.com/cgi-bin/prnh/20010924/CGM015LOGO ) Here are the highlights from the Featured Expert column: The Dow was on track Thursday for its fourth-straight day of losses -- down over 11 points to close at 9911.69, while the Nasdaq gained 7 1/2 points to close at 1631.91. There was a great deal of concern over the military posturing by India and Pakistan, which was one of the many factors that caused the Dow to re-test its early-May lows of 9807.69. There are reports that President Bush is going to send Defense Secretary Rumsfeld to India-Pakistan to help resolve the troubling standoff. Other contributing factors included the fact that jobless claims are at a 19-year high after increasing 49K the week of May 18; further weakening in the dollar due to continued concern over the economic recovery in the U.S., continued mistrust of corporate accounting practices; and a lack of leadership from any influential industry groups. Many sectors limited the market's progress on Thursday including; oil drilling, airlines, utilities, auto parts, apparel and brokerage shares. DTI's Stocks to Watch Network Appliance (NASDAQ:NTAP): A storage play DTI picked up on recent weakness. Network Appliance hardware, software, and service offerings are used to create, manage and scale seamless data fabrics, moving information to users globally. DTI has a short-term target of $15.50. (For further price targets see their Small Cap Newsletter) Protein Design Labs (NASDAQ:PDLI): A biotech play DTI picked up on recent weakness. Protein Design Labs is engaged in the development of humanized monoclonal antibodies for the prevention and treatment of disease. DTI has a short-term target of $15.00. (For further price targets see their Small Cap Newsletter) To get a FREE and PROFITABLE stock pick every trading day for the next 30 days, click: https://www.featuredexpert3.zacks.com . About Zacks Featured Experts To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets ... and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc. Stock Picks from Featured Experts Highlighted in FREE Investment Newsletter The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts and their hottest stock picks in this free e-mail newsletter. Get your free subscription to "Profit from the Pros" at: https://www.freeprofit1.zacks.com . About Zacks Zacks.com is a property of Zacks Investment Research (CRD#7874), which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit https://www.freeprofit2.zacks.com . Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. For more information, contact: Terry Batey of Zacks.com, 312-630-9880, ext. 307, email, [e-mail] . Visit: www.Zacks.com MAKE YOUR OPINION COUNT - Click Here https://tbutton.prnewswire.com/prn/11690X88574461 SOURCE Zacks Investment Research -0- 06/03/2002 /CONTACT: Terry Batey of Zacks.com, [phone], ext. 307, email, [e-mail] / /Photo: https://www.newscom.com/cgi-bin/prnh/20010924/CGM015LOGO AP Archive: https://photoarchive.ap.org PRN Photo Desk, [phone] or [phone]/ /Web site: https://www.featuredexpert2.zacks.com https://www.featuredexpert3.zacks.com https://www.freeprofit1.zacks.com https://www.freeprofit2.zacks.com https://www.zacks.com / - - - - -